The magnitude of CXCR4 signaling regulates resistance to quizartinib in FLT3/ITD(+) cells via RUNX1. Fukuda S, Matsuda N, Shoji T, Onishi C, et al. Leuk Res 2023;124:106983.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fukuda S, Matsuda N, Shoji T, Onishi C, et al. The magnitude of CXCR4 signaling regulates resistance to quizartinib in FLT3/ITD(+) cells via RUNX1. Leuk Res 2023;124:106983.
PMID: 36473282